- Home
- CENX vs FBIOP Comparison
CENX vs FBIOP Comparison
Compare CENX & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENX
- FBIOP
- Stock Information
- Founded
- CENX 1995
- FBIOP N/A
- Country
- CENX United States
- FBIOP United States
- Employees
- CENX N/A
- FBIOP 101
- Industry
- CENX Aluminum
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- CENX Industrials
- FBIOP Health Care
- Exchange
- CENX Nasdaq
- FBIOP Nasdaq
- Market Cap
- CENX 1.5B
- FBIOP N/A
- IPO Year
- CENX 1996
- FBIOP N/A
- Fundamental
- Price
- CENX $15.51
- FBIOP $6.15
- Analyst Decision
- CENX Strong Buy
- FBIOP
- Analyst Count
- CENX 3
- FBIOP 0
- Target Price
- CENX $23.00
- FBIOP N/A
- AVG Volume (30 Days)
- CENX 1.5M
- FBIOP N/A
- Earning Date
- CENX 05-07-2025
- FBIOP N/A
- Dividend Yield
- CENX N/A
- FBIOP N/A
- EPS Growth
- CENX 35.22
- FBIOP N/A
- EPS
- CENX 3.12
- FBIOP N/A
- Revenue
- CENX $2,223,300,000.00
- FBIOP N/A
- Revenue This Year
- CENX $6.79
- FBIOP N/A
- Revenue Next Year
- CENX $3.58
- FBIOP N/A
- P/E Ratio
- CENX $5.05
- FBIOP N/A
- Revenue Growth
- CENX 4.75
- FBIOP N/A
- 52 Week Low
- CENX $11.40
- FBIOP N/A
- 52 Week High
- CENX $25.39
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- CENX 41.68
- FBIOP 47.56
- Support Level
- CENX $15.71
- FBIOP $6.36
- Resistance Level
- CENX $17.57
- FBIOP $6.80
- Average True Range (ATR)
- CENX 0.79
- FBIOP 0.37
- MACD
- CENX 0.03
- FBIOP 0.01
- Stochastic Oscillator
- CENX 26.33
- FBIOP 45.52
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.